Search Results - "Burge, Matthew"

Trifluridine/tipiracil: A practical guide to its use in the management of refractory metastatic colorectal cancer in Australia.

Authors: Price, Timothy Burge, Matthew Chantrill, Lorraine et al.

Source: Asia Pacific Journal of Clinical Oncology. Apr2020 Supplement S1, Vol. 16, p3-12. 10p.

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].

Authors: Clarke, Stephen John Burge, Matthew Feeney, Kynan et al.

Source: PLoS ONE. 3/6/2020, Vol. 15 Issue 3, p1-11. 11p.

Impact of the evolution in RAS mutation analysis in Australian patients with metastatic colorectal cancer.

Authors: Chong, Chia Yuen Jalali, Azim Wong, Hui Li et al.

Source: Asia Pacific Journal of Clinical Oncology. Oct2022, Vol. 18 Issue 5, pe363-e368. 6p.

Establishing high risk factors for recurrence in stage I/II colorectal cancer: a metropolitan perspective.

Authors: Wood, Phoebe C. Zammit, Andrew P. Ferris, Baillie et al.

Source: World Journal of Surgical Oncology. 6/18/2025, Vol. 23 Issue 1, p1-8. 8p.

The Therapeutic Landscape for KRAS -Mutated Colorectal Cancers.

Authors: Tria, Simon Manuel Burge, Matthew E. Whitehall, Vicki L. J.

Source: Cancers. Apr2023, Vol. 15 Issue 8, p2375. 25p.

Prospective, open‐label, and observational study of cetuximab for metastatic colorectal carcinoma: The OPTIM1SE study.

Authors: Yang, Tsai‐Sheng Chen, Hong‐Hwa Bo‐Wen, Lin et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2023, Vol. 19 Issue 6, p672-680. 9p.

Recurrent Convolutional Deep Neural Networks for Modeling Time-Resolved Wildfire Spread Behavior.

Authors: Burge, John Bonanni, Matthew R. Hu, R. Lily et al.

Source: Fire Technology; Nov2023, Vol. 59 Issue 6, p3327-3354, 28p

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Authors: Gan, Hui K. Burge, Matthew Solomon, Benjamin et al.

Source: Journal of Nuclear Medicine. Dec2021, Vol. 62 Issue 12, p1-29. 30p.

A Phase 1 and Biodistribution Study of ABT-806i, An Indium-111 Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806.

Authors: Hui K. Gan Burge, Matthew Solomon, Benjamin et al.

Source: Journal of Nuclear Medicine. 8/1/2021, Vol. 62 Issue 8, p1-30. 30p.

Use and outcomes from neoadjuvant chemotherapy in borderline resectable pancreatic ductal adenocarcinoma in an Australasian population.

Authors: Walpole, Imogen Lee, Belinda Shapiro, Jeremy et al.

Source: Asia Pacific Journal of Clinical Oncology. Feb2023, Vol. 19 Issue 1, p214-225. 12p.

Patient demographics and management landscape of metastatic colorectal cancer in the third‐line setting: Real‐world data in an australian population.

Authors: Min, Sandy Tun Roohullah, Aflah Tognela, Annette et al.

Source: Asia Pacific Journal of Clinical Oncology. Apr2022, Vol. 18 Issue 2, pe56-e63. 8p.

First‐line therapy for metastatic colorectal cancer: Current perspectives and future directions.

Authors: Burge, Matthew Price, Timothy Karapetis, Christos S.

Source: Asia Pacific Journal of Clinical Oncology. Feb2019 Supplement S1, Vol. 15, p3-14. 12p.

Right versus left sided metastatic colorectal cancer: Teasing out clinicopathologic drivers of disparity in survival.

Authors: Mendis, Shehara Kosmider, Suzanne Ananda, Sumitra et al.

Source: Asia Pacific Journal of Clinical Oncology. Jun2019, Vol. 15 Issue 3, p136-143. 8p.

MRI rectal cancer in Australia and New Zealand: An audit from the PETACC-6 trial.

Authors: Gormly, Kirsten L Coscia, Claudio Wells, Tim et al.

Source: Journal of Medical Imaging & Radiation Oncology. Oct2016, Vol. 60 Issue 5, p607-615. 9p.

Effects of a Structured Exercise Program on Physical Activity and Fitness in Colon Cancer Survivors: One Year Feasibility Results from the CHALLENGE Trial.

Authors: Courneya, Kerry S. Vardy, Janette L. O'Callaghan, Christopher J. et al.

Source: Cancer Epidemiology, Biomarkers & Prevention. Jun2016, Vol. 25 Issue 6, p969-977.

Cancer on the margins: experiences of living with neuroendocrine tumours.

Authors: Plage, Stefanie Gibson, Alexandra Burge, Matthew et al.

Source: Health Sociology Review. Jul2018, Vol. 27 Issue 2, p153-167. 15p.

Effectiveness of bevacizumab and cetuximab in metastatic colorectal cancer across selected public hospitals in Queensland.

Authors: Chapman, Suzannah J McKavanagh, Daniel Burge, Matthew E et al.

Source: Asia Pacific Journal of Clinical Oncology. Oct2017, Vol. 13 Issue 5, pe253-e261. 9p.

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study.

Authors: Tie, Jeanne Wang, Yuxuan Cohen, Joshua et al.

Source: PLoS Medicine. 5/3/2021, Vol. 18 Issue 5, p1-16. 16p. 2 Diagrams, 2 Charts, 4 Graphs.

Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study.

Authors: Kuchel, Anna Ahern, Elizabeth Collins, Stephanie et al.

Source: Asia Pacific Journal of Clinical Oncology. Feb2021, Vol. 17 Issue 1, p84-93. 10p.

Successful treatment of a primary mediastinal germ cell tumour complicated by hemophagocytic syndrome.

Authors: BURGE, Matthew ISLAM, Mohammed F MORRIS, Kirk et al.

Source: Asia Pacific Journal of Clinical Oncology. Dec2012, Vol. 8 Issue 4, pe97-e98. 2p.